Vanguard U.S. Multifactor Fund ABBV Holdings History
Vanguard U.S. Multifactor Fund's AbbVie Inc Holding Summary
As of 2025-02-28, VANGUARD WELLINGTON FUND held - shares of AbbVie Inc(ABBV), totaling N/A. This investment constitutes 0% of their stock portfolio, and VANGUARD WELLINGTON FUND now holds 0% of the outstanding AbbVie Inc(ABBV) stock.
The initial trade took place in 2021Q4. And since then Vanguard U.S. Multifactor Fund has made 4 purchases of ABBV, at an average price of $143.57, for a total of 5,948.00 shares. In addition, there have been 3 sales at an average price of $174.82 for 5,948.00 shares. Based on historical transaction data and ABBV's current price of $192.47, Vanguard U.S. Multifactor Fund's estimated gain on his ABBV holdings is $185,865.22, reflecting a 21.77% gain to date.
Vanguard U.S. Multifactor Fund ABBV ($192.47) Holding Chart
Vanguard U.S. Multifactor Fund ABBV ($192.47) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
